In addition to its own research programs, BioNet actively in-licenses technologies and participates into research and development collaborations. We combine a broad range of expertise in process development, analytical and animal testing and clinical evaluation, along with significant experience in patenting and business to assess market opportunities and devise an optimised commercialisation strategy for each individual technology.
BioNet has been continuously collaborating with biotech companies, public organizations and universities in Thailand and abroad for vaccine research and development:
Product Development Partnerships (Dengue)
In-licensing Agreement (Hepatitis)
Collaborative Research Agreement (Pertussis)
We flexibly and pragmatically design agreements with commercial entities to provide them with a strong incentive to evaluate, develop and exploit the licensed technology. We ensure that the licensees have the technical expertise and the commercial capabilities to take licensed technology to market including the securing of regulatory approvals.